A new Cochrane review bolsters confidence in the safety and effectiveness of RSV vaccines for older adults and pregnant ...

Enanta Pharmaceuticals said on Monday its treatment for respiratory syncytial virus failed to shorten the time taken to reduce the severity of some symptoms, missing the primary goal of a mid-stage ...

A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in ...

Bayo Curry-Winchell, MD explains why RSV can be dangerous to older adults. Washington turned down 170 custom license plates ...

Investors were spooked by the miss, and shares in Nasdaq-listed Enanta were down around 11%, having risen sharply in ...

Enata Pharmaceuticals said it didn't meet its primary endpoint in a Phase 2b study of zelicapavir, its proposed treatment for Respiratory Syncytial Virus, or RSV, in high-risk adults.

A new Cochrane review demonstrates that respiratory syncytial virus (RSV) vaccines are safe and effective in protecting ...

A doctor has cautioned that a frustrating Covid symptom may become "worse at night". The specialist noted that this ...

Dr Sooj said: "It can affect anyone but it usually affects young children particularly those who are preschool-aged and it's ...

Vaccines are the most cost-effective health intervention after clean water. They reduce health inequities, lower health-care ...

With the start of fall also comes the start of cold and flu season. New recommendations from the Centers for Disease Control ...